BioSpace News Archive

Yiling Pharmaceutical announced that Lianhua Qingwen capsules have been added to the “Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme for Laos” as the fourth traditional Chinese medicine to treat COVID-19 pneumonia in Laos.

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced that it will release financial results for the first quarter ended March 31, 2020 before the market open on Monday, May 4, 2020.

iCAD, Inc. announced it has entered into definitive agreements with several institutional investors for the purchase and sale of 1,562,500 shares of the Company’s common stock at $8.00 per share, pursuant to a registered direct offering.

Idera Pharmaceuticals, Inc. announced that updates on ILLUMINATE-206 and ILLUMINATE-101, two studies investigating intratumoral tilsotolimod, Idera’s investigational Toll-like receptor 9 agonist, will be presented at the American Association for Cancer Research Virtual Annual Meeting I, to be held April 27-28, 2020, as part of a “Clinical Trial Poster Session.”.

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company, is pleased to announce that it has received approval from the Ministry of Food and Drug Safety in South Korea, as well as ethics approval, for an investigator-led, Phase 2 COVID-19 clinical study of its re-purposed drug NP-120 (Ifenprodil), an NMDA receptor antagonist. Th

Proceeds enable advancement of lead program into clinical development and support progression of additional programs

QIAGEN N.V. announced that it plans to release its report on results for the first quarter 2020 results on Wednesday, May 6, at approximately 22:05 Central European Time / 16:05 Eastern Day Time..

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it entered into a $15 million common stock purchase agreement and registration rights agreement with Lincoln Park Capital Fund, LLC (“LPC”), a Chicago-based institutional investor. Under the terms and conditions of the purchase agreement, Daré will have the right, from time to time and at its sole discretion, to sell up to $15 million of its stock to LP

Athenex, Inc. announced that it will release first quarter 2020 financial results on Thursday, May 7, 2020, before the market opens, and host a conference call and live audio webcast 8:00am Eastern Time to discuss the financial results and provide a business update.

Establishment Labs Holdings Inc., a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended March 31, 2020 after the market closes on Thursday, May 7, 2020, and will host a conference call at 5:00 pm ET that day to discuss those results.